CD99 and neoplasm: Further immunohistochemical studies showed that the tumor cells were positive for vimentin and p16; had focal weak positivity for SMA; had moderate positivity for TLE-1; and were negative for p63, EMA, AE1/AE3 antibodies, c-Kit, S100, CD31, CD34, desmin, myogenin, melan A, HMB45 antibody, ALK-1, human herpesvirus 8 (HHV8), CD99 (MIC-2) and SRY-box 10 (SOX10).